Last Update 13/11/2023
Completion Time 1 hour 19 minutes
Members 2
    • Anti-Microbial Resistance: How Do We Detect and Prevent It?

Presenter

Dr Jackie Stone

Mr Evans Musara

BIO

Dr Jackie Stone, medical director and clinical lead at Intellectus Campus. She is a Zimbabwean Primary Care Physician who grew up in Zimbabwe. She graduated from the University of Cape Town Cum Laude in 1989. She went on to get a Medical Research Council Scholarship to do an Honours degree in Medical Biochemistry which she completed in 1992. From there she went to the UK and worked in the Infection and Immunity Department at St Bartholomew's Hospital in London and wrote her MRCP in 1996. She then moved to the Middle East and worked in the Airline industry for 12 years. In 2003 she was part of the airline's SARS 1 task force. She completed her Diploma in Aviation Medicine in 2008 from Kings College in London. This she feels taught her a great deal about Risk Benefit Assessment, Hypoxia, Infectious disease treatment and prevention and vaccination. In 2008 she moved to Australia and completed her FRACGP in 2012. She also became an inaugural member of the Australasian College of Aerospace Medicine in 2012. Both in the Middle East and Australia she developed an interest in Integrative Medicine. She returned to Zimbabwe in 2015 for personal reasons and is now on the Executive Committee of the Zimbabwe Covid Front Line Clinicians Society who advocate for saving lives through early, safe, effective, affordable combination therapy.


Mr Evans Musara, is an accomplished professional in the field of biopharmaceuticals and biotechnology, with 7 years in Pharmaceutical manufacturing, research and development as well as quality control systems. He holds a Bachelor of Honors degree in Applied Biology and Biochemistry, which he earned at the Namibian University of Science and Technology and having previously worked in Marketing at New Avakash, in 2021, together with Dr Naik, they came up with an idea to develop formulations for microbiological culture media which could then be used in disease diagnostics andn many other microbiology laboratory applications, giving birth to Avacell Biotechnology. Thus currently serving as the Managing Director of Avacell Biotechnology, Mr Musara’s leadership reflects his vision for innovation, quality and sustainable growth in the industry. And given his dedication to driving success through unwavering commitment and expertise, his presentation should reflect his professional acumen and unyielding commitment to Avacell Biotechnology.